EVLO — Evelo Biosciences Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
U.S. STOCKS ON THE MOVE-DXC Technology, Nvidia, Lisata Therapeutics
Evelo Bio slumps after skin disease drug fails in mid-stage study
U.S. STOCKS ON THE MOVE-Nvidia, Westlake, North American steel companies
U.S. STOCKS ON THE MOVE-TMC, PayPal, TOMI
Evelo Biosciences rises on smaller Q2 loss
Evelo Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Evelo Biosciences Q2 EPS USD -3.78
Brief: Evelo Biosciences Announces Second Quarter Financial Results
Brief: Evelo Biosciences Inc Files For Shelf Of Up To 13.2 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
Evelo Biosciences Inc expected to post a loss of $3.30 a share - Earnings Preview
Brief: Harbourvest Partners Reports 8.8% Passive Stake In Evelo Biosciences Inc As Of July 11 - SEC Filing
Brief: Evelo Biosciences Closes $25.5 Million Private Placement
Brief: Evelo Biosciences Announces $25.5 Million Private Placement
Brief: Evelo Biosciences Announces Reverse Stock Split
U.S. STOCKS ON THE MOVE-iRobot, Nikola, Adobe
Brief: Evelo Biosciences Board Terminates Executive Severance Plan
Evelo Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Evelo Biosciences Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Hoth Therapeutics, Activision Blizzard, Getaround